Safety of inactivated SARS-CoV-2 vaccines in patients with allergic diseases

Safety of inactivated SARS-CoV-2 vaccines in patients with allergic diseases

Abstract Background Considering the considerable prevalence of allergic disease in the general population, an urgent need exists for inactivated SARS-CoV-2 vaccines that can be safely administered to those subjects. Methods This retrospective cohort study including 1926 participants who received ina...

Full description

Bibliographic Details
Main Authors: Chao Cao, Feng Qiu, Chengcheng Lou, Lingling Fang, Fang Liu, Jingjing Zhong, Weijie Sun, Weiping Ding, Xiaopin Yu, Qinhong Xu, Ran Wang, Liemin Ruan, Qifa Song
Format: Article
Language:English
Published: BMC 2022-05-01
Series:Respiratory Research
Subjects:
SARS-CoV-2
Vaccine
Allergic diseases
Safety
Immunogenicity
Online Access:https://doi.org/10.1186/s12931-022-02054-1

Internet

https://doi.org/10.1186/s12931-022-02054-1

Similar Items